Exscientia plc (Nasdaq: EXAI) will report financial results for the third quarter ended September 30, 2023 on November 9, 2023, prior to the start of U.S. stock markets. At 1:30 p.m. GMT / 8:30 a.m. EST, the company will provide a conference call and webcast to provide a business update and financial results.
The webcast of the live conference call can be accessed on the Company’s website at investors.exscientia.ai in the Investors and Media section. Alternatively, you can access the live conference call by telephone using the dial-in numbers +1 (888) 330 3292 (USA), +44 203 433 3846 (Great Britain) or +1 (646) 960 0857 (international) after entering the conference ID 8333895 possible. A replay will be available for 90 days on the Exscientia website in the Investors and Media section under Events and Presentations.
About Exscientia
Exscientia is an AI-powered precision medicine company dedicated to researching, designing and developing the best possible active ingredients in the fastest and most effective way. Exscientia has developed the first functional precision oncology platform that has successfully guided treatment choice and improved patient outcomes in a prospective clinical intervention study. It also brings small molecules developed with the help of AI into the clinical setting. Our internal pipeline focuses on the application of our precision medicine platform in oncology, while our partner pipeline expands our approach to other therapeutic areas. As a pioneer of a new strategy in drug development, we believe that the best scientific ideas can quickly be developed into the best medicines for patients.
Visit us at https://www.exscientia.ai or follow us on X/Twitter: @exscientiaAI.
The source language in which the original text is published is the official and authorized version. Translations will be included for a better understanding. Only the language version that was originally published is legally valid. Therefore, compare translations with the original language version of the publication.
View original version on businesswire.com: https://www.businesswire.com/news/home/20231102717693/de/
Selected leverage products on Exscientia
With knock-outs, speculative investors can participate disproportionately in price movements. Simply select the lever you want and we will show you suitable open-end products on Exscientia
The leverage must be between 2 and 20
Advertising